TUScholarShare will be undergoing an upgrade from February 17th – March 4th, 2025. During this time, content in the repository will still be accessible for viewing and downloading, but no new content will be deposited to the repository. All deposit forms will remain functional and new content will continue to be accepted. However, new content submitted for deposit during this time will not be made live in the repository until the upgrade has been completed. If you have any questions, please contact scholarshare@temple.edu.

Show simple item record

dc.creatorBreve, Frank
dc.creatorBatastini, Lisa
dc.creatorLeQuang, Jo Ann K.
dc.creatorMarchando, Gina
dc.date.accessioned2024-01-03T20:45:55Z
dc.date.available2024-01-03T20:45:55Z
dc.date.issued2022-03-16
dc.identifier.citationBreve F, Batastini L, LeQuang J K, et al. (March 16, 2022) Mobile Narcotic Treatment Programs: On the Road Again?. Cureus 14(3): e23221. doi:10.7759/cureus.23221
dc.identifier.issn2168-8184
dc.identifier.urihttp://hdl.handle.net/20.500.12613/9416
dc.description.abstractMany Americans with opioid use disorder (OUD), do not have access to treatment. Mobile narcotic treatment programs are now under new regulations that may make treatment more accessible to more people. These mobile programs can help expand the reach of opioid agonist treatment for OUD, help reduce human immunodeficiency viruses (HIV) and hepatitis C in the OUD population, and have retention rates that are often better than those at fixed-site clinics. Mobile services can also help reach marginalized individuals, the homeless, rural communities, and other underserved communities. They may offer methadone or buprenorphine treatment. Such mobile services have been used inside and outside the United States with promising results. In particular, mobile programs can make treatment available to people who do not have insurance, who lack reliable transportation, live in chaotic situations, or may be undomiciled. The potential pairing of mobile programs together with technology, such as smartphone apps or online resources, may allow mobile patients to benefit from counseling as well. Mobile clinics must be attached to a fixed-site narcotic treatment program and may have limitations with respect to the geographic area served. Mobile programs must have policies and procedures to store, transport, deliver, account for, reconcile, and dispose of opioid waste and would be subject to audit. Mobile opioid agonist therapy is an important and innovative service of particular value to underserved communities.
dc.format.extent7 pages
dc.languageEnglish
dc.language.isoeng
dc.relation.ispartofFaculty/ Researcher Works
dc.relation.haspartCureus, Vol. 14
dc.relation.isreferencedbySpringer
dc.rightsAttribution CC BY
dc.rights.urihttps://creativecommons.org/licenses/by/4.0/
dc.subjectOpioid use disorder
dc.subjectOpioid rehabilitation
dc.subjectMobile narcotic treatment program
dc.subjectMobile methadone clinic
dc.subjectMethadone
dc.subjectBuprenorphine
dc.titleMobile Narcotic Treatment Programs: On the Road Again?
dc.typeText
dc.type.genreJournal article
dc.relation.doihttp://dx.doi.org/10.7759/cureus.23221
dc.ada.noteFor Americans with Disabilities Act (ADA) accommodation, including help with reading this content, please contact scholarshare@temple.edu
dc.description.schoolcollegeTemple University. School of Pharmacy
dc.temple.creatorBreve, Frank
refterms.dateFOA2024-01-03T20:45:55Z


Files in this item

Thumbnail
Name:
BreveEtAl-JournalArticle-2022- ...
Size:
344.7Kb
Format:
PDF

This item appears in the following Collection(s)

Show simple item record

Attribution CC BY
Except where otherwise noted, this item's license is described as Attribution CC BY